论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
苦参中的生物活性植物化学物质对乳腺癌的抗肿瘤活性
Authors Cao X, He Q
Received 20 December 2019
Accepted for publication 5 February 2020
Published 27 February 2020 Volume 2020:12 Pages 1457—1467
DOI https://doi.org/10.2147/CMAR.S243127
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Antonella D'Anneo
Abstract: Patients with breast cancer and breast cancer survivors are frequent users of botanicals and their bioactive phytochemicals. In China, active ingredients in Sophora flavescens like matrine (MT), oxymatrine (OMT), other Sophora flavescens alkaloids and Compound Kushen Injection (CKI) are extensively used for multiple malignant tumors. In vivo and in vitro studies have confirmed that these activities or injection have significant effects on relieving symptoms, alleviating side effects after chemotherapy and improving the quality of life of breast cancer patients, where there is evidence for efficacy. A large number of experimental studies have also revealed that they can inhibit the proliferation, invasion and migration of breast cancer cells according to different mechanisms. This provides promising valuable supportive therapies for prevention, treatment and postoperative recovery of breast cancer. Rigorous clinical research and experimental studies reflect integrative care as it is used in hospital is needed to responsibly move this field forward. This review summarizes an up to date knowledge of the available bioactive phytochemicals, their discovery, current clinical and experimental status.
Keywords: breast cancer, Sophora flavescens , CKI, matrine, oxymatrine
